What is the ticker symbol for Verrica Pharmaceuticals?

Verrica Pharmaceuticals trades under the ticker VRCA on NASDAQ.

What sector does Verrica Pharmaceuticals operate in?

Verrica Pharmaceuticals is classified in the Healthcare sector (Biotechnology industry).

How can PortView help analyze VRCA in a portfolio?

PortView shows VRCA's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.

Verrica Pharmaceuticals (VRCA) Stock Analysis

NASDAQHealthcareBiotechnology

$5.41+3.24%

1-year price historyRange $3.28 – $9.10

52-week range$5.41

$3.28$9.82

What Verrica Pharmaceuticals does

Verrica Pharmaceuticals Inc., a dermatology therapeutics company, engages in the development and commercialization of medications for the treatment of dermatologic diseases in the United States. The company offers YCANTH (VP-102) a drug-device combination that contains a GMP-controlled formulation of cantharidin for the treatment of molluscum in adult and pediatric patients, as well as for the treatment of common warts. It also develops VP-315, an oncolytic peptide-based injectable therapy that is in phase II clinical trial for the treatment of dermatology oncologic conditions, which include basal cell carcinoma and other dermatological oncology indications. The company has a collaboration and license agreement with Torii Pharmaceutical Co., Ltd. for the development and commercialization of its product candidates for the treatment of molluscum and common warts in Japan; and a license agreement with Lytix Biopharma AS to develop and commercialize VP-315 for use in malignant and pre-malignant dermatological indications. Verrica Pharmaceuticals Inc. was incorporated in 2013 and is headquartered in West Chester, Pennsylvania.

Key metrics

Market cap

$92.94M

P/E (TTM)

-6.60

EPS (TTM)

$-0.82

Beta

1.49

Dividend yield

0.00%

Revenue / share

$1.42

50-day avg

$5.51

200-day avg

$6.23

52-week high

$9.82

52-week low

$3.28

CEO

Jayson Rieger

ETFs linked to VRCA

Broad-market and Healthcare sector ETFs an investor holding Verrica Pharmaceuticals is often also exposed to. Open an ETF page to see its actual top holdings.

SPY — SPDR S&P 500 ETF Trust VOO — Vanguard S&P 500 ETF QQQ — Invesco QQQ Trust VTI — Vanguard Total Stock Market ETF

PortView Portfolio Insights

PortView analyzes how VRCA fits your actual portfolio — position weight, portfolio concentration, unrealized gain/loss, contribution to return, sector exposure, indirect exposure through the ETFs you hold, and correlation with your other holdings. Connect a portfolio to see your personalized figures; PortView never shows another user's private holdings.

Analyze VRCA in PortView →

Similar companies

JNJ — Johnson &LLY — Eli Lilly A — Agilent Technologies ABBV — AbbVie Inc.ABT — Abbott Laboratories ALNY — Alnylam Pharmaceuticals

Frequently asked questions

What is the ticker symbol for Verrica Pharmaceuticals?: Verrica Pharmaceuticals trades under the ticker VRCA on NASDAQ.
Which exchange is VRCA listed on?: VRCA is listed on NASDAQ.
What sector does Verrica Pharmaceuticals operate in?: Verrica Pharmaceuticals is classified in the Healthcare sector (Biotechnology industry).
How can PortView help analyze VRCA in a portfolio?: PortView shows VRCA's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.

The information provided by PortView is for informational and educational purposes only and does not constitute investment advice. Market data may be delayed. Past performance does not guarantee future results.